| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/06/2001 | US6197931 Human marco scavenger receptor |
| 03/06/2001 | US6197930 Polypeptide for use in organ preservation, cryopreservation, for surgical pretreatment to prevent injury due to inflammation; antiischemic agents |
| 03/06/2001 | US6197926 Protein segments for prevention of preferential pancreas defect |
| 03/06/2001 | US6197925 NF-AT polypeptides and polynucleotides |
| 03/06/2001 | US6197836 Preparation of active ingredient dispersions and apparatus therefor |
| 03/06/2001 | US6197794 Antiinflamamtory agents; immunology diseases |
| 03/06/2001 | US6197782 Therapy for sexual disorders |
| 03/06/2001 | US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 03/06/2001 | US6197755 Compositions and methods for delivery of genetic material |
| 03/06/2001 | US6197754 Tyrosine kinase inhibitor |
| 03/06/2001 | US6197751 Thymosin α1 promotes tissue repair, angiogenesis and cell migration |
| 03/06/2001 | US6197750 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/06/2001 | US6197749 Method of suppressing immune responses by reducing intracellular content of glutathione in macrophages and monocytes |
| 03/06/2001 | US6197748 Ketoheterocyclic inhibitors of factor Xa |
| 03/06/2001 | US6197746 Method of using secretin for treating autism |
| 03/06/2001 | US6197745 Methods for producing nitrosated hemoglobins and therapeutic uses therefor |
| 03/06/2001 | US6197744 Tumor necrosis factor inhibitory protein tip B1 and method of using same |
| 03/06/2001 | US6197584 Antisense modulation of CD40 expression |
| 03/06/2001 | US6197583 Therapeutic compounds |
| 03/06/2001 | US6197581 Human adenylate cyclase and use therefor |
| 03/06/2001 | US6197580 Transcriptional regulation of the human β3-adrenergic receptor gene |
| 03/06/2001 | US6197578 Cells expressing both human CD4 and a human fusion accessory factor associated with HIV infection |
| 03/06/2001 | US6197571 Protein polysaccharide 0041 |
| 03/06/2001 | US6197566 α-galactosidase enzyme |
| 03/06/2001 | US6197550 Nucleotide sequences which code for proteins of transforming growth factor-beta family of defined amino acid sequences; for recombinant production; wound healing agents; treatment of bone, liver, and kidney disorders |
| 03/06/2001 | US6197549 Amino acid and nucleotide sequences of aminoacylase from staphylococcus; drug screening of bactericides for treatment of infections |
| 03/06/2001 | US6197546 PcrA Helicase of Staphylococcus aureus |
| 03/06/2001 | US6197543 Human vesicle membrane protein-like proteins |
| 03/06/2001 | US6197541 Nucleic acid which codes for mammalian receptor having seven transmembrane domains; drug screening of anticoagulants and wound healing agents; diagnosis of cardiovascular disorders; treatment of restenosis and unstable angina |
| 03/06/2001 | US6197530 GPR10 as a target for identifying weight modulating compounds |
| 03/06/2001 | US6197528 Composition of immunotoxins and retinoids and use thereof |
| 03/06/2001 | US6197525 Kit for detection of interleukin-17, interleukin-17 receptor, antagonists, or mimetics; includes receptor protein of defined amino acid sequence and a detecting reagent; for identifying immunosuppressants |
| 03/06/2001 | US6197524 Methods for detecting, identifying, isolating, and selectively labelling and targeting TH1 lymphocyte by means of the LAG-3 protein |
| 03/06/2001 | US6197521 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 03/06/2001 | US6197519 Pancreas-derived serpin |
| 03/06/2001 | US6197517 Drug screening by contacting protein coded by gene yfr003c, ygr277c, ygr278w, ykr071c, ykr079c, or ykr083c with test compound where binding of protein and compound indicates fungicide |
| 03/06/2001 | US6197512 Human myosin heavy chain-like proteins and method of detecting nucleic acid encoding said proteins |
| 03/06/2001 | US6197511 Amino acid sequence; diagosis and treatment of cancer and skin disorders; anticarcinogenic agents; recombinant production; hybridization probes |
| 03/06/2001 | US6197350 Method of producing a sustained-release preparation |
| 03/06/2001 | US6197337 Decreasing atherosclerosis in humans and animals |
| 03/06/2001 | US6197335 Dissolving cyclosporins with anionic surfactants |
| 03/06/2001 | US6197333 Materials and methods for making improved liposome compositions |
| 03/06/2001 | US6197330 System for the treatment of wounds |
| 03/06/2001 | US6197328 Nasally administrable compositions |
| 03/06/2001 | US6197325 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 03/06/2001 | US6197312 Surface antigen |
| 03/06/2001 | US6197302 Administering fusion protein of major histocompatibility complex complexed to immunoglobulin constant domain |
| 03/06/2001 | US6197301 Compositions and methods for the prevention and diagnosis of Lyme disease |
| 03/06/2001 | US6197300 ftsZ |
| 03/06/2001 | US6197297 Monoclonal antibody specific to polypeptide which induces interferon-gamma production |
| 03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
| 03/06/2001 | US6197292 A canine(dog) interferon-gamma lacking 16 amino acids from its c-terminus and a carrier is useful for topical application of skin for canine suffering from dermatitis |
| 03/06/2001 | US6197291 Administering dehydroepiandrosterone sulfate or a pharmaceutically acceptable salt as an active ingredient, for potentiating the effect of interleukin-8 for promoting the maturity of uterine cervix in late phase pregnancy |
| 03/06/2001 | US6197194 Single use system for preparing autologous plasma and fibrin gel |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/06/2001 | CA2021379C Pentapeptide antibiotics derived from dalbaheptides |
| 03/06/2001 | CA1341197C Gm-csf protein, its derivatives, the preparation of proteins of this type, and their use |
| 03/06/2001 | CA1341196C Process for the preparation of substituted imino diacids |
| 03/01/2001 | WO2001014593A2 A method for producing quality assured biological sample and composition containing the same |
| 03/01/2001 | WO2001014581A2 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 03/01/2001 | WO2001014570A1 Activatable recombinant neurotoxins |
| 03/01/2001 | WO2001014564A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | WO2001014557A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | WO2001014556A1 Novel b7-4 molecules and uses therefor |
| 03/01/2001 | WO2001014554A1 G protein-coupled receptor expressed in brain |
| 03/01/2001 | WO2001014553A1 Compositions isolated from bovine mammary gland and methods for their use |
| 03/01/2001 | WO2001014552A1 Meg-1 protein |
| 03/01/2001 | WO2001014551A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2 |
| 03/01/2001 | WO2001014549A1 Gas1 polypeptides |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014545A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 03/01/2001 | WO2001014535A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 03/01/2001 | WO2001014523A1 TktA |
| 03/01/2001 | WO2001014424A2 Human ctla-4 antibodies and their uses |
| 03/01/2001 | WO2001014421A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 03/01/2001 | WO2001014420A2 Novel members of the plexin family and uses thereof |
| 03/01/2001 | WO2001014418A2 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
| 03/01/2001 | WO2001014415A2 Egfh2 genes and gene products |
| 03/01/2001 | WO2001014414A2 Human abc2 transporter and uses thereof |
| 03/01/2001 | WO2001014413A2 Polypeptides capable of interacting with the smad peptide and comprising the sequence pp (t/n)k |
| 03/01/2001 | WO2001014412A1 Compounds useful to mimic peptide beta-strands |
| 03/01/2001 | WO2001014402A1 Antisense modulation of focal adhesion kinase expression |
| 03/01/2001 | WO2001014400A1 2'-o-acetamido modified monomers and oligomers |
| 03/01/2001 | WO2001014368A1 Compounds, compositions and methods for treating influenza |
| 03/01/2001 | WO2001014320A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | WO2001014318A2 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | WO2001013967A1 Solid wound healing formulations containing fibronectin |
| 03/01/2001 | WO2001013960A1 Methods for in vivo gene delivery to sites of cartilage damage |
| 03/01/2001 | WO2001013959A1 Method for knocking out gene expression by covalently binding antisense probes |
| 03/01/2001 | WO2001013957A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | WO2001013951A1 Chondrogenesis promoters |
| 03/01/2001 | WO2001013946A2 Method for isolating and purifying grass pollen allergens |
| 03/01/2001 | WO2001013940A1 Hm1.24 antigen expression potentiators |
| 03/01/2001 | WO2001013939A1 High density lipoprotein against organ dysfunction following haemorrhagic shock |
| 03/01/2001 | WO2001013938A1 Medicinal composition for percutaneous/permucosal absorption |
| 03/01/2001 | WO2001013937A1 Peptides capable of modulating the function of cd66 (ceacam) family members |
| 03/01/2001 | WO2001013936A1 Induced regeneration and repair of damaged neurons and nerve axon myelin |
| 03/01/2001 | WO2001013935A2 Modulation of the blood-brain barrier transporter for leptin |
| 03/01/2001 | WO2001013934A1 Peptide and peptide analogues for the treatment and prevention of diabetes |